ROSEN LEGAL FIRM URGES INSP STOCK INVESTORS TO SECURE REPRESENTATION BEFORE CLASS ACTION DEADLINE

ROSEN, a globally recognized law firm, continues to encourage shareholders of Inspire Medical Systems, Inc. INSP who have suffered significant losses to contact the firm in advance of an important deadline. This communication is aimed at investors seeking to participate in a securities class action lawsuit which has been filed on behalf of Inspire Medical Systems investors.

About Inspire Medical Systems

Inspire Medical Systems, Inc. INSP, headquartered in Golden Valley, Minnesota, is a medical technology company singularly focused on providing innovative treatments for people suffering from Obstructive Sleep Apnea (OSA). With their advanced, minimally invasive solutions available in the United States and Europe, they aim to improve the health and quality of life for those affected by this prevalent condition.

The Allegations Against Inspire Medical Systems

The class action filed against Inspire Medical Systems, Inc. charges the company with misleading statements or failing to disclose information pertinent to investors. Shareholders who have witnessed a substantial drop in the value of their INSP investment and who wish to take action are being prompted by ROSEN to seek legal counsel prior to the class action lawsuit deadline.

Investor Participation

Investors with a substantial financial interest in INSP stocks are being advised that joining the class action can potentially aid in the recovery of personal investment losses. Additionally, it offers the opportunity to hold Inspire Medical Systems accountable for their alleged corporate misconduct. The class action is not exclusive to any one investor, and those who have suffered losses are urged to consider their legal rights and options.

ROSEN, INSP, Investment